Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Proleukin Observational Registry to Evaluate the Treatment Patterns and Clinical Response in Malignancy

NCT01415167 is registered in ClinicalTrials.gov with Prometheus Laboratories as lead sponsor.

NCT NCT01415167
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01415167 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Proleukin Observational Registry to Evaluate the Treatment Patterns and Clinical Response in Malignancy
Lead sponsor
Prometheus Laboratories
Phase
Observational
Overall status
Completed
Start date
August 31, 2011
Completion date
May 31, 2018
Enrollment
1,690 (actual)
Sites
45

Conditions

As the registry lists them; a condition with its own page is linked.

metastatic melanoma, metastatic renal cell carcinoma